PMV Pharmaceuticals PMVP
NASDAQ PMVP
$1.26 +0.04 (+3.28%)
At close: Nov 11, 2026 · 4:00 PM EST

PMV Pharmaceuticals (PMVP) Return on Assets [ROA] (2020 - 2026)

Updated

PMV Pharmaceuticals (PMVP) posted Return on Assets [ROA] of -84.22% for Q2 2026, down 34.21 percentage points from -50.00% a year earlier and down 10.70 percentage points from the prior quarter.

Analysis

PMV Pharmaceuticals (PMVP) Return on Assets [ROA] (2020 - 2026) Analysis & Trends

For FY2025, PMV Pharmaceuticals' Return on Assets [ROA] came in at -50.51%, down 24.03 percentage points from FY2024.

  • Annual Return on Assets [ROA] has declined for five consecutive years, with a five-year change of -35.81 percentage points (FY2020 to FY2025).
  • In prior years, PMV Pharmaceuticals' Return on Assets [ROA] was -26.48% in FY2024 (-0.08 pp), -26.40% in FY2023 (-2.04 pp), -24.36% in FY2022 (-7.77 pp) and -16.60% in FY2021 (-1.90 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Assets [ROA] in data going back to Q4 2020.
  • On a year-over-year basis, Return on Assets [ROA] has declined in each of the last seven quarters, with an average year-over-year change of -21.82 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2024, with a gain of 9.28 percentage points; the weakest was Q1 2026, with a drop of 39.88 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -73.52% (Q1 2026), -62.09% (Q4 2025) and -57.69% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 PMV Pharmaceuticals 80.80 Mn -307.68 Mn - -91.78%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -91.78%
Jun 30, 2026 -84.33%
Mar 31, 2026 -73.61%
Dec 31, 2025 -62.14%
Sep 30, 2025 -57.92%
Jun 30, 2025 -49.88%
Mar 31, 2025 -33.52%
Dec 31, 2024 -28.35%
Sep 30, 2024 -21.99%
Jun 30, 2024 -20.55%
Mar 31, 2024 -26.63%
Dec 31, 2023 -26.61%
Sep 30, 2023 -28.57%
Jun 30, 2023 -29.60%
Mar 31, 2023 -28.02%
Dec 31, 2022 -26.54%
Sep 30, 2022 -25.06%
Jun 30, 2022 -22.79%
Mar 31, 2022 -20.21%
Dec 31, 2021 -17.14%
API Access

PMV Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PMVP&period=max&api_key=YOUR_API_KEY